The detection of ESR1 mutations in ctDNA through liquid biopsy allows the molecular evaluation of the tumor using a minimally invasive alternative to solid tissue-based genotyping [6,8,19,[24], [25], [26], [27], [28]]. Here, ESR1 is linked to neoplasm.